CCO Treatment Updates
Optimal Treatment of Locally Advanced/Metastatic Pancreatic Cancer: Current Progress and Future Challenges
Progress in Pancreatic Cancer: Where Are We Now and Where Must We Go?
|
Module 1 of 2
|
|
|
|
 In this module, Manuel Hidalgo, MD, PhD, provides an overview of current concepts in diagnosis, evaluation, and treatment of pancreatic cancer. Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the epidemiology, risk factors, pathological classification, and genetic abnormalities associated with pancreatic cancer
- Describe the potential role of biomarkers in early detection, screening, and therapeutic decision making in patients with pancreatic cancer
- Describe current treatment options for patients with pancreatic cancer, including surgical resection, adjuvant and neoadjuvant treatments, and therapy for advanced disease
|
Optimal Treatment of Advanced/Metastatic Pancreatic Cancer: Current Progress and Future Challenges
|
Module 2 of 2
|
 
- Malcolm J. Moore, MD
- Neesha Dhani, MD, FRCPC
|
|
|
Neesha Dhani, MD, and Malcolm J. Moore, MD, provide a concise overview of the current status of pancreatic cancer treatment as well as emerging therapeutic agents and combinations of agents for patients with advanced disease. Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize current treatment options for patients with advanced/metastatic pancreatic cancer
- Describe novel agents and drug combinations in clinical evaluation for the treatment of advanced pancreatic cancer
- Discuss specific genetic mutations and signaling pathways critical to the pathogenesis of pancreatic cancer
|
CCO Slidesets
Advances in Pancreatic Cancer
 |
|
This slideset from Malcolm J. Moore, MD, and Neesha Dhani, MD, includes a review of current management strategies and treatments for patients with pancreatic cancer.
Format: Microsoft PowerPoint (.ppt) | File size: 859 KB
|
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grant provided by:
Educational grants support only the CME-certified components of this program.
|
|